Current Landscape of Immunotherapy in Breast Cancer

2019404 citationsJournal Articlegreen Open Access

Authors

Sylvia Adams · NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Margaret E. Gatti‐Mays · National Cancer Institute

Kevin Kalinsky · Columbia University Irving Medical Center

Larissa A. Korde · National Cancer Institute

Elad Sharon · National Cancer Institute

Laleh Amiri‐Kordestani · United States Food and Drug Administration

Harry D. Bear

Abstract

It is anticipated that combination therapy strategies will be the way forward for immunotherapy in breast cancer, with an improved understanding of tumor, microenvironment, and host factors informing treatment combination decisions. Thoughtful study design incorporating appropriate end points and correlative studies will be critical in identifying optimal strategies for enhancing the immune response against breast tumors.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Cancer, Stress, Anesthesia, and Immune Response

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 5, Issue 8, pp. 1205-1205

DOI: 10.1001/jamaoncol.2018.7147

Field-Weighted Citation Impact: 21.70